Skip to content

Clinical trials

Recruiting Prostatic Neoplasms, Castration-Resistant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms, Castration-Resistant Status: Recruiting Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20212
20222
20234
20246
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Janssen Research & Development, LLC2
Merck Sharp & Dohme LLC2
Astellas Pharma Global Development, Inc.1
Bristol-Myers Squibb1
Cancer Research UK1
Celcuity Inc1
Clarity Pharmaceuticals Ltd1
Flare Therapeutics Inc.1
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms, Castration-Resistant24
Prostatic Neoplasms9
Neoplasms6
Genital Diseases, Male3
Male Urogenital Diseases3
Neoplasm Metastasis3
Neoplasms by Site3
Prostatic Diseases3
Colorectal Neoplasms2
Endometrial Neoplasms2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.